US EditionPublished • loading... • Updated
PTC Therapeutics (NASDAQ:PTCT) CAO Sells $172,983.84 in Stock
CAO Christine Marie Utter sold 2,494 shares, reducing her stake by 3.43%, amid a quarterly earnings per share miss of $1.67 versus $0.21 consensus, according to SEC filings.
Summary by defenseworld.net
1 Articles
1 Articles
PTC Therapeutics (NASDAQ:PTCT) CAO Sells $172,983.84 in Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CAO Christine Marie Utter sold 2,494 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $69.36, for a total value of $172,983.84. Following the completion of the sale, the chief accounting officer directly owned 70,199 shares of the company’s stock, valued at $4,869,002.64. This represents a 3.43% decrease in their owne…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
